4.0 Article

Ensuring buprenorphine access in rural community pharmacies to prevent overdoses

Related references

Note: Only part of the references are listed.
Article Health Care Sciences & Services

Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder

C. Holly A. Andrilla et al.

Summary: The number of clinicians with a DEA waiver to prescribe buprenorphine for OUD more than doubled between December 2017 and July 2020, reaching 98,344. While access to MOUD has increased across all geographic categories, there are still disparities in treatment availability in small rural communities, and significant regional differences by US Census Division.

JOURNAL OF RURAL HEALTH (2022)

Article Substance Abuse

Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study

Daniel J. Ventricelli et al.

SUBSTANCE USE & MISUSE (2020)

Editorial Material Medicine, General & Internal

When Prescribing Isn't Enough - Pharmacy-Level Barriers to Buprenorphine Access

Hannah L. F. Cooper et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Health Care Sciences & Services

What Is Rural? Challenges And Implications Of Definitions That Inadequately Encompass Rural People And Places

Kevin J. Bennett et al.

HEALTH AFFAIRS (2019)

Article Psychology, Clinical

Price elasticity of demand for buprenorphine/naloxone prescriptions

Chandler McClellan et al.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2019)

Article Public, Environmental & Occupational Health

Opioid Overdose Mortality Among Former North Carolina Inmates: 2000-2015

Shabbar I. Ranapurwala et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2018)